AANEM News Express

AANEM News Express

Guideline Released for Facioscapulohumeral Muscular Dystrophy (FSHD)

7/28/2015
 
A new guideline from the American Academy of Neurology (AAN) and the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) looks at the scientific studies on facioscapulohumeral muscular dystrophy (FSHD). 

FSHD is a genetic muscle disorder in which the muscles of the face, shoulder blades and upper arms are among the most affected and is the third most common form of muscular dystrophy (MD).  While there is no cure for this disorder, health care providers need to be aware of and help to manage associated health problems. Genetic testing is available to confirm the majority of cases of FSHD.

The FSHD guideline is to be published in the July 28, 2015, online issue of Neurology®, the medical journal of the American Academy of Neurology. The full guideline can also be found on AANEM’s website. This new guideline is based on the best available studies on FSHD, and can inform the public and clinicians about the best approach to managing and treating this disease.


View Related News Stories:

  Practicemuscular dystrophyFSHDguidelines


Recent AANEM News

Recap: 2019 AMA House of Delegates Annual Meeting

Science News: Efficacy of Botulinum Toxin A for Treating Cramps in Diabetic Neuropathy

Science News: Diagnostic Sensitivity of Electrophysiology and Ultrasonography in Ulnar Neuropathies of Different Severity

Science News: Long-term Effect of Thymectomy Plus Prednisone Versus Prednisone Alone in Patients with Non-thymomatous Myasthenia Gravis: 2-year Extension of the MGTX Randomised Trial

AANEM Returns to Capitol for 6th Annual Hill Day





Advertisement

TPP

Advertisement

ABEM

Advertisement

Find Your Dream Job